Transport of cosalane—A highly lipophilic novel anti-HIV agent—Across Caco-2 cell monolayers

Journal of Pharmaceutical Sciences

Volumn 89, Issue 6, 2000, Pages 826-833

  Pal, Dhananjay ^a   Udata, Chandrasekhar ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Biophysical model; Caco 2 cell line; Cosalane; HIV; Transport

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BOVINE SERUM ALBUMIN; COSALANE; GLYCOPROTEIN;

ARTICLE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; DRUG SOLUBILITY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LIPOPHILICITY; PARTITION COEFFICIENT;

EID: 0033822279     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6017(200006)89:6<826::AID-JPS15>3.0.CO;2-4     Document Type: Article

References (25)

1. Design, synthesis and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction
2. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease integrase
3. Design and synthesis of cosalane, a novel anti-HIV agent
4. Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues
5. Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements
6. Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid
7. Pharmacokinetics, biliary excretion and tissue distribution of cosalane and dihydrocosalane, novel anti-HIV agents, in SD rats
8. Disposition of cosalane, a novel anti-HIV agent, in isolated perfused rat livers
9. Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers
10. Transcellular permeability of chlorpromazin demonstrating the roles of protein binding and membrane partitioning
11. Characterization of human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
12. Epithelial transport of drugs in cell culture. I. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
13. Role of p-glycoprotein and cytochrome p450 3A in limiting oral absorption of peptides and peptidomimetics
14. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs
15. Interplay between cyp3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers
16. Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
17. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestine) absorption in man - Fact or myth
18. MDCK (Mardin-Darby Canine Kidney) cells: A tool for membrane permeability screening
19. Characterization of an 'in vivo' blood-brain barrier: Effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs
20. High lipophilicity decreased drug transport across intestinal epithelial cells
21. A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain
22. Transepithelial transport of aliphatic carboxylic acids studied in madian darby canine kidney (MDCK) cell monolayers
23. Role of capillary endothelium in the clearance of chylomicrons. A model for lipid transport from blood by lateral diffusion in cell membranes
24. A new method for quantitating intercellular transport: Application to the thyroid hormone 3,5,3'-triiodothyroinine
25. Mechanism of cholesterol efflux from cells